PSA secretion and cell proliferation are affected by NCoR1 silencing in prostate cancer cells

Detalhes bibliográficos
Autor(a) principal: Costa, Bruna Pasqualotto
Data de Publicação: 2020
Outros Autores: Brum, Ilma Simoni, Pizzolato, Lolita Schneider, Biolchi, Vanderlei, Branchini, Gisele
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinical and Biomedical Research
Texto Completo: https://seer.ufrgs.br/index.php/hcpa/article/view/97205
Resumo: The androgen receptor (AR) plays an important role in normal prostate gland development as well as in prostatic neoplasms. Transcriptional regulation by AR is modulated by its interaction with co-activators or co-repressors, such as NCoR1 (nuclear receptor co-repressor 1), which is involved in the reduction of AR activity over the target gene transcription. To identify the role of NCoR1 in the prostate cancer androgen independence in a cell line model, we aimed to evaluate the effects of silencing NCoR1 on prostate-specific antigen (PSA) gene expression, the proliferative response and PSA secretion on the supernatant of C4-2B and LNCaP cells that were submitted to small interfering RNAs (siRNAs) transfection and to treatments with different androgen dosages. In LNCaP and C4-2B cells with no dihydrotestosterone (DHT) treatment, a decrease of PSA mRNA expression was observed 48 hours and 72 hours after gene silencing in the siNCoR group when compared to the control and siNC groups. LNCaP and C4-2B cells showed a biphasic pattern in response to dihydrotestosterone treatment in transfected groups (siNCoR and siNC) as well as in the control condition (no transfection). The secretion of PSA in cell supernatant of LNCaP and C4-2B cells was higher in the siNCoR group, and, regarding the hormonal treatment, higher in the 10-8 M DHT group. A reduction in the levels of NCoR1 seems to have a double influence on the activity of AR in PCa cells. These results suggest that NCoR can act as AR a co-repressor depending upon hormonal stimulation.
id UFRGS-20_2212961cad765d7ed8eb92fe996d9a8c
oai_identifier_str oai:seer.ufrgs.br:article/97205
network_acronym_str UFRGS-20
network_name_str Clinical and Biomedical Research
repository_id_str
spelling PSA secretion and cell proliferation are affected by NCoR1 silencing in prostate cancer cellsProstatic neoplasmscastration-resistanprostatic neoplasmNCoR1gene silencingThe androgen receptor (AR) plays an important role in normal prostate gland development as well as in prostatic neoplasms. Transcriptional regulation by AR is modulated by its interaction with co-activators or co-repressors, such as NCoR1 (nuclear receptor co-repressor 1), which is involved in the reduction of AR activity over the target gene transcription. To identify the role of NCoR1 in the prostate cancer androgen independence in a cell line model, we aimed to evaluate the effects of silencing NCoR1 on prostate-specific antigen (PSA) gene expression, the proliferative response and PSA secretion on the supernatant of C4-2B and LNCaP cells that were submitted to small interfering RNAs (siRNAs) transfection and to treatments with different androgen dosages. In LNCaP and C4-2B cells with no dihydrotestosterone (DHT) treatment, a decrease of PSA mRNA expression was observed 48 hours and 72 hours after gene silencing in the siNCoR group when compared to the control and siNC groups. LNCaP and C4-2B cells showed a biphasic pattern in response to dihydrotestosterone treatment in transfected groups (siNCoR and siNC) as well as in the control condition (no transfection). The secretion of PSA in cell supernatant of LNCaP and C4-2B cells was higher in the siNCoR group, and, regarding the hormonal treatment, higher in the 10-8 M DHT group. A reduction in the levels of NCoR1 seems to have a double influence on the activity of AR in PCa cells. These results suggest that NCoR can act as AR a co-repressor depending upon hormonal stimulation.HCPA/FAMED/UFRGS2020-07-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/97205Clinical & Biomedical Research; Vol. 40 No. 1 (2020)Clinical and Biomedical Research; v. 40 n. 1 (2020)2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSenghttps://seer.ufrgs.br/index.php/hcpa/article/view/97205/pdfCopyright (c) 2020 Clinical and Biomedical Researchinfo:eu-repo/semantics/openAccessCosta, Bruna PasqualottoBrum, Ilma SimoniPizzolato, Lolita SchneiderBiolchi, VanderleiBranchini, Gisele2022-09-13T18:49:12Zoai:seer.ufrgs.br:article/97205Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2022-09-13T18:49:12Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.none.fl_str_mv PSA secretion and cell proliferation are affected by NCoR1 silencing in prostate cancer cells
title PSA secretion and cell proliferation are affected by NCoR1 silencing in prostate cancer cells
spellingShingle PSA secretion and cell proliferation are affected by NCoR1 silencing in prostate cancer cells
Costa, Bruna Pasqualotto
Prostatic neoplasms
castration-resistan
prostatic neoplasm
NCoR1
gene silencing
title_short PSA secretion and cell proliferation are affected by NCoR1 silencing in prostate cancer cells
title_full PSA secretion and cell proliferation are affected by NCoR1 silencing in prostate cancer cells
title_fullStr PSA secretion and cell proliferation are affected by NCoR1 silencing in prostate cancer cells
title_full_unstemmed PSA secretion and cell proliferation are affected by NCoR1 silencing in prostate cancer cells
title_sort PSA secretion and cell proliferation are affected by NCoR1 silencing in prostate cancer cells
author Costa, Bruna Pasqualotto
author_facet Costa, Bruna Pasqualotto
Brum, Ilma Simoni
Pizzolato, Lolita Schneider
Biolchi, Vanderlei
Branchini, Gisele
author_role author
author2 Brum, Ilma Simoni
Pizzolato, Lolita Schneider
Biolchi, Vanderlei
Branchini, Gisele
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Costa, Bruna Pasqualotto
Brum, Ilma Simoni
Pizzolato, Lolita Schneider
Biolchi, Vanderlei
Branchini, Gisele
dc.subject.por.fl_str_mv Prostatic neoplasms
castration-resistan
prostatic neoplasm
NCoR1
gene silencing
topic Prostatic neoplasms
castration-resistan
prostatic neoplasm
NCoR1
gene silencing
description The androgen receptor (AR) plays an important role in normal prostate gland development as well as in prostatic neoplasms. Transcriptional regulation by AR is modulated by its interaction with co-activators or co-repressors, such as NCoR1 (nuclear receptor co-repressor 1), which is involved in the reduction of AR activity over the target gene transcription. To identify the role of NCoR1 in the prostate cancer androgen independence in a cell line model, we aimed to evaluate the effects of silencing NCoR1 on prostate-specific antigen (PSA) gene expression, the proliferative response and PSA secretion on the supernatant of C4-2B and LNCaP cells that were submitted to small interfering RNAs (siRNAs) transfection and to treatments with different androgen dosages. In LNCaP and C4-2B cells with no dihydrotestosterone (DHT) treatment, a decrease of PSA mRNA expression was observed 48 hours and 72 hours after gene silencing in the siNCoR group when compared to the control and siNC groups. LNCaP and C4-2B cells showed a biphasic pattern in response to dihydrotestosterone treatment in transfected groups (siNCoR and siNC) as well as in the control condition (no transfection). The secretion of PSA in cell supernatant of LNCaP and C4-2B cells was higher in the siNCoR group, and, regarding the hormonal treatment, higher in the 10-8 M DHT group. A reduction in the levels of NCoR1 seems to have a double influence on the activity of AR in PCa cells. These results suggest that NCoR can act as AR a co-repressor depending upon hormonal stimulation.
publishDate 2020
dc.date.none.fl_str_mv 2020-07-15
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/97205
url https://seer.ufrgs.br/index.php/hcpa/article/view/97205
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://seer.ufrgs.br/index.php/hcpa/article/view/97205/pdf
dc.rights.driver.fl_str_mv Copyright (c) 2020 Clinical and Biomedical Research
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Clinical and Biomedical Research
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv HCPA/FAMED/UFRGS
publisher.none.fl_str_mv HCPA/FAMED/UFRGS
dc.source.none.fl_str_mv Clinical & Biomedical Research; Vol. 40 No. 1 (2020)
Clinical and Biomedical Research; v. 40 n. 1 (2020)
2357-9730
reponame:Clinical and Biomedical Research
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Clinical and Biomedical Research
collection Clinical and Biomedical Research
repository.name.fl_str_mv Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv ||cbr@hcpa.edu.br
_version_ 1750135158659350528